NIH funding of COVID-19 research in 2020: a cross-sectional study.
- 2022
CONCLUSION: In the first year of the pandemic, the NIH diverted a small fraction of its budget to COVID-19 research. Future health emergencies will require research funding to pivot in a timely fashion and funding levels to be proportional to the anticipated burden of disease in the population. Copyright © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. DESIGN: Cross-sectional study. MAIN OUTCOMES AND MEASURES: The primary outcome was to determine the number of grants and funding amount the NIH allocated for COVID-19 by research type and clinical/scientific area. The secondary outcome was to calculate the time from the funding opportunity announcement to the award notice date. OBJECTIVE: This study aims to characterise and evaluate the National Institutes of Health's (NIH's) grant allocation speed and pattern of COVID-19 research. PARTICIPANTS: 1108 grants allocated to COVID-19 research. RESULTS: The NIH awarded a total of 56 169 grants in 2020, of which 2.0% (n=1108) wwas allocated for COVID-19 research. The NIH had a US SETTING: COVID-19 NIH RePORTER Dataset was used to identify COVID-19 relevant grants.
English
ISSN: 2044-6055
Standard No.: 10.1136/bmjopen-2021-059041 [doi] bmjopen-2021-059041 [pii] PMC9096053 [pmc]
Subjects--Topical Terms: *Biomedical Research *COVID-19 COVID-19/ep [Epidemiology] Cross-Sectional Studies Financing, Organized Humans National Institutes of Health (U.S.) United States
Subjects--Geographic Terms: MedStar Washington Hospital Center
Index Terms--Occupation: Nursing
Index Terms--Function: Journal Article Research Support, Non-U.S. Gov't